The abstract is read at the publisher; the summary is JClub's.
Sepsis-associated endotheliopathy follows a dynamic, phenotype- and trajectory-oriented progression from endothelial activation to functional disruption, structural injury, and organ-specific vascular failure.
- Why it matters: Sepsis endothelial dysfunction is not uniform, so clinicians lack a framework to map evolving vascular states to measurable biomarkers, bedside signals, and risk stratification.
- What they did: This Review proposes a framework integrating clinical modes, molecular mechanisms, biology-anchored biomarker panels, bedside physiological surrogates, and serial trajectory-based assessment.
- The result: The approach supports identifying endothelial states, refining risk stratification, and informing biomarker-enriched trials, microvascular-informed resuscitation, and endotype-guided endothelial cell-targeted therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.